Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.

Jin, Lei; Ma, Xuemei; Zhang, Nan; Zhang, Qian; Chen, Xueming; Zhang, Zhongtao; Ding, Guoqian; Yu, Hongzhi

Jin, Lei; Ma, Xuemei; Zhang, Nan; Zhang, Qian; Chen, Xueming; Zhang, Zhongtao; Ding, Guoqian; Yu, Hongzhi.

Afiliación

Jin L; Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Ma X; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhang N; Department of Radiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Zhang Q; Clinical Epidemiology and EBM Center, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Chen X; Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Ding G; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Yu H; Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.

Cancer Manag Res ; 13: 8599-8609, 2021.

Article en En | MEDLINE | ID: mdl-34815714

Palabras clave

bioinformatic analysis; biomarker; cisplatin resistance; gastric cancer; miR-181a-2-3p

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google